{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:25:12Z","timestamp":1786469112130,"version":"build-2736575974"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T00:00:00Z","timestamp":1172016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>Rabbit anti\u2010thymocyte globulin (ATG) and alemtuzumab have been used for induction or preconditioning and for the treatment of acute rejection in organ transplant recipients in many centers. Such regimens may lead to a substantial decline in the CD4 lymphocyte count to levels seen in other population groups at high risk of cryptococcosis. In view of this, we examined the impact of such therapy on the cumulative incidence of cryptococcosis among liver and kidney recipients. A total of 834 liver and 727 kidney transplants were performed during the study period. Seven hundred and eighty\u2010one patients did not receive ATG or alemtuzumab; 646 received 1 dose of either drug, and 134 patients received 2 doses of either drug. The cumulative incidence of cryptococcosis was 0.26% (2\/781) among those who did not receive ATG or alemtuzumab; 0.3% (2\/646) among those who received only 1 dose, and 2.24% (3\/134) among those who received 2 doses (<jats:italic>P<\/jats:italic>=0.03). There were 5 cases of cryptococcosis in liver recipients and 2 in kidney recipients. There were 3 cases of cryptococcal meningitis, 3 of pneumonia, and 1 of disseminated disease. The 2 kidney recipients had meningitis. Diagnosis occurred at a median of 255 days (range 7\u2013517) after transplantation. The mortality rate was 14.2%. We conclude that the use of 1 dose of ATG or alemtuzumab is not associated with an increased cumulative incidence of cryptococcosis, but that those patients receiving 2 doses are at increased risk.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2006.00149.x","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T13:32:46Z","timestamp":1172064766000},"page":"22-27","source":"Crossref","is-referenced-by-count":77,"title":["Cryptococcosis in liver and kidney transplant recipients receiving anti\u2010thymocyte globulin or alemtuzumab"],"prefix":"10.1111","volume":"9","author":[{"given":"F.P.","family":"Silveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.P.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,2,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.d01-650.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403258"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403561"},{"key":"e_1_2_6_5_2","first-page":"142","article-title":"Immunological reconstitution after bone marrow transplant with Campath\u20101 treated bone marrow","volume":"67","author":"Parreira A","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00879.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.12.131"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2003.tb00309.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.32261"},{"key":"e_1_2_6_10_2","first-page":"375","article-title":"Cryptococcus neoformans infection in organ transplant recipients","volume":"7","author":"Husain S","year":"2001","journal-title":"variables influencing clinical characteristics and outcome"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.6.1163"},{"key":"e_1_2_6_12_2","first-page":"575","article-title":"Cryptococcosis in organ transplant recipients","volume":"2","author":"Vilchez RA","year":"2002","journal-title":"an overview"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/339548"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-56-1-114"},{"key":"e_1_2_6_15_2","first-page":"549","article-title":"High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression","volume":"5","author":"Bach MC","year":"1973","journal-title":"Transplant Proc"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/jb.100.3.1271-1276.1969","article-title":"Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans","volume":"100","author":"Adamson DM","year":"1969","journal-title":"J Bacteriol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(02)00036-3"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.6.1029"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-533"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-2-234"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909213211205"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199705000-00016"},{"key":"e_1_2_6_23_2","first-page":"770","article-title":"Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV\u2010infected persons","volume":"4","author":"Crowe SM","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_24_2","first-page":"966","article-title":"Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation","volume":"78","author":"Marcos A","year":"2004","journal-title":"with particular reference to hepatitis C virus"},{"key":"e_1_2_6_25_2","first-page":"722","article-title":"Campath\u20101H induction plus rapamycin monotherapy for renal transplantation","volume":"3","author":"Knechtle SJ","year":"2003","journal-title":"results of a pilot study"},{"key":"e_1_2_6_26_2","first-page":"77","article-title":"Immune cell function testing","volume":"17","author":"Kowalski R","year":"2003","journal-title":"an adjunct to therapeutic drug monitoring in transplant patient management"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00375.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403636"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04514.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1385\/MO:19:4:277"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.37668.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/375690"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.01.054"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00822.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199601150-00027"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-0012.1997.tb00783.x","article-title":"Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus","volume":"11","author":"Singh N","year":"1997","journal-title":"Clin Transplant"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1975.00330090035004"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.136.6.670"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.1.119"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2006.00149.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2006.00149.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:03:16Z","timestamp":1736812996000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2006.00149.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,21]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1399-3062.2006.00149.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2006.00149.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,21]]}}}